nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—panic disorder—Bupropion—obesity	0.176	0.561	CpDpCtD
Paroxetine—bipolar disorder—Topiramate—obesity	0.138	0.439	CpDpCtD
Paroxetine—SLC6A4—obesity	0.0768	0.565	CbGaD
Paroxetine—HTR2A—obesity	0.059	0.435	CbGaD
Paroxetine—SLC6A3—Diethylpropion—obesity	0.0304	0.0826	CbGbCtD
Paroxetine—SLC6A3—Phendimetrazine—obesity	0.0231	0.0626	CbGbCtD
Paroxetine—SLC6A3—Sibutramine—obesity	0.0231	0.0626	CbGbCtD
Paroxetine—SLC6A2—Diethylpropion—obesity	0.0223	0.0604	CbGbCtD
Paroxetine—SLC6A4—Sibutramine—obesity	0.0202	0.0547	CbGbCtD
Paroxetine—SLC6A3—Benzphetamine—obesity	0.0175	0.0474	CbGbCtD
Paroxetine—SLC6A3—Phentermine—obesity	0.0175	0.0474	CbGbCtD
Paroxetine—SLC6A2—Sibutramine—obesity	0.0169	0.0458	CbGbCtD
Paroxetine—SLC6A2—Phendimetrazine—obesity	0.0169	0.0458	CbGbCtD
Paroxetine—SLC6A3—Phenylpropanolamine—obesity	0.0167	0.0452	CbGbCtD
Paroxetine—SLC6A4—Phentermine—obesity	0.0153	0.0415	CbGbCtD
Paroxetine—SLC6A3—Bupropion—obesity	0.0149	0.0403	CbGbCtD
Paroxetine—SLC6A3—Methamphetamine—obesity	0.014	0.0379	CbGbCtD
Paroxetine—SLC6A2—Phentermine—obesity	0.0128	0.0347	CbGbCtD
Paroxetine—SLC6A2—Benzphetamine—obesity	0.0128	0.0347	CbGbCtD
Paroxetine—SLC6A4—Methamphetamine—obesity	0.0122	0.0332	CbGbCtD
Paroxetine—SLC6A2—Phenylpropanolamine—obesity	0.0122	0.0331	CbGbCtD
Paroxetine—SLC6A2—Bupropion—obesity	0.0109	0.0295	CbGbCtD
Paroxetine—SLC6A2—Methamphetamine—obesity	0.0102	0.0277	CbGbCtD
Paroxetine—CYP2B6—Benzphetamine—obesity	0.00794	0.0215	CbGbCtD
Paroxetine—CYP2B6—Bupropion—obesity	0.00675	0.0183	CbGbCtD
Paroxetine—CYP2C8—Bupropion—obesity	0.00511	0.0139	CbGbCtD
Paroxetine—CYP2C9—Phentermine—obesity	0.0042	0.0114	CbGbCtD
Paroxetine—TACR1—vagus nerve—obesity	0.00403	0.177	CbGeAlD
Paroxetine—CYP2D6—Phentermine—obesity	0.00384	0.0104	CbGbCtD
Paroxetine—CYP2C8—Cimetidine—obesity	0.00375	0.0102	CbGbCtD
Paroxetine—CYP2C9—Bupropion—obesity	0.00357	0.00967	CbGbCtD
Paroxetine—CYP2D6—Bupropion—obesity	0.00326	0.00885	CbGbCtD
Paroxetine—CYP2D6—Methamphetamine—obesity	0.00307	0.00832	CbGbCtD
Paroxetine—CYP2C9—Cimetidine—obesity	0.00262	0.0071	CbGbCtD
Paroxetine—ABCB1—Cimetidine—obesity	0.00254	0.00689	CbGbCtD
Paroxetine—CYP2D6—Cimetidine—obesity	0.00239	0.00649	CbGbCtD
Paroxetine—CHRM3—muscle of abdomen—obesity	0.00207	0.0911	CbGeAlD
Paroxetine—SLC6A2—sympathetic nervous system—obesity	0.00169	0.0741	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—obesity	0.00113	0.0498	CbGeAlD
Paroxetine—HTR2A—sympathetic nervous system—obesity	0.00101	0.0445	CbGeAlD
Paroxetine—HTR2A—vagus nerve—obesity	0.000982	0.0431	CbGeAlD
Paroxetine—TACR1—respiratory system—obesity	0.000719	0.0316	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—obesity	0.000682	0.0299	CbGeAlD
Paroxetine—SLC6A3—hindbrain—obesity	0.000592	0.026	CbGeAlD
Paroxetine—SLC6A4—hindbrain—obesity	0.000543	0.0238	CbGeAlD
Paroxetine—TACR1—adipose tissue—obesity	0.000486	0.0213	CbGeAlD
Paroxetine—TACR1—digestive system—obesity	0.000457	0.0201	CbGeAlD
Paroxetine—TACR1—adrenal gland—obesity	0.000436	0.0191	CbGeAlD
Paroxetine—TACR1—endocrine gland—obesity	0.000378	0.0166	CbGeAlD
Paroxetine—SLC6A3—respiratory system—obesity	0.000362	0.0159	CbGeAlD
Paroxetine—SLC6A4—respiratory system—obesity	0.000331	0.0146	CbGeAlD
Paroxetine—SLC6A2—respiratory system—obesity	0.000292	0.0128	CbGeAlD
Paroxetine—HTR2A—hindbrain—obesity	0.000287	0.0126	CbGeAlD
Paroxetine—CHRM2—cardiovascular system—obesity	0.000278	0.0122	CbGeAlD
Paroxetine—CYP2D6—hindbrain—obesity	0.000262	0.0115	CbGeAlD
Paroxetine—CHRM1—cardiovascular system—obesity	0.000253	0.0111	CbGeAlD
Paroxetine—CYP2B6—respiratory system—obesity	0.000215	0.00944	CbGeAlD
Paroxetine—SLC6A4—digestive system—obesity	0.000211	0.00926	CbGeAlD
Paroxetine—CHRM3—adipose tissue—obesity	0.0002	0.00876	CbGeAlD
Paroxetine—CHRM2—endocrine gland—obesity	0.000191	0.00837	CbGeAlD
Paroxetine—CHRM3—digestive system—obesity	0.000188	0.00825	CbGeAlD
Paroxetine—CYP2B6—adrenal cortex—obesity	0.00018	0.00793	CbGeAlD
Paroxetine—SLC6A2—adrenal gland—obesity	0.000177	0.00776	CbGeAlD
Paroxetine—HTR2A—respiratory system—obesity	0.000175	0.0077	CbGeAlD
Paroxetine—SLC6A4—endocrine gland—obesity	0.000174	0.00765	CbGeAlD
Paroxetine—CHRM1—endocrine gland—obesity	0.000173	0.00762	CbGeAlD
Paroxetine—CYP2B6—cardiovascular system—obesity	0.000165	0.00723	CbGeAlD
Paroxetine—CYP2C9—cardiovascular system—obesity	0.000163	0.00716	CbGeAlD
Paroxetine—CYP2C8—pituitary gland—obesity	0.000163	0.00714	CbGeAlD
Paroxetine—CHRM3—endocrine gland—obesity	0.000155	0.00682	CbGeAlD
Paroxetine—SLC6A2—endocrine gland—obesity	0.000153	0.00673	CbGeAlD
Paroxetine—CYP2B6—digestive system—obesity	0.000137	0.006	CbGeAlD
Paroxetine—CYP2C9—digestive system—obesity	0.000135	0.00595	CbGeAlD
Paroxetine—HTR2A—cardiovascular system—obesity	0.000134	0.0059	CbGeAlD
Paroxetine—CYP2B6—adrenal gland—obesity	0.00013	0.00572	CbGeAlD
Paroxetine—CYP2C8—endocrine gland—obesity	0.000126	0.00553	CbGeAlD
Paroxetine—ABCB1—islet of Langerhans—obesity	0.000122	0.00535	CbGeAlD
Paroxetine—HTR2A—pituitary gland—obesity	0.000119	0.00522	CbGeAlD
Paroxetine—ABCB1—respiratory system—obesity	0.000115	0.00505	CbGeAlD
Paroxetine—CYP2C8—liver—obesity	0.000114	0.00499	CbGeAlD
Paroxetine—CYP2B6—endocrine gland—obesity	0.000113	0.00496	CbGeAlD
Paroxetine—CYP2C9—endocrine gland—obesity	0.000112	0.00491	CbGeAlD
Paroxetine—HTR2A—digestive system—obesity	0.000112	0.0049	CbGeAlD
Paroxetine—HTR2A—adrenal gland—obesity	0.000106	0.00467	CbGeAlD
Paroxetine—CYP2B6—liver—obesity	0.000102	0.00447	CbGeAlD
Paroxetine—CYP2D6—digestive system—obesity	0.000102	0.00446	CbGeAlD
Paroxetine—CYP2C9—liver—obesity	0.000101	0.00443	CbGeAlD
Paroxetine—ABCB1—adrenal cortex—obesity	9.65e-05	0.00424	CbGeAlD
Paroxetine—HTR2A—endocrine gland—obesity	9.21e-05	0.00405	CbGeAlD
Paroxetine—ABCB1—cardiovascular system—obesity	8.8e-05	0.00387	CbGeAlD
Paroxetine—CYP2D6—endocrine gland—obesity	8.39e-05	0.00369	CbGeAlD
Paroxetine—HTR2A—liver—obesity	8.31e-05	0.00365	CbGeAlD
Paroxetine—ABCB1—pituitary gland—obesity	7.79e-05	0.00342	CbGeAlD
Paroxetine—ABCB1—adipose tissue—obesity	7.76e-05	0.00341	CbGeAlD
Paroxetine—CYP2D6—liver—obesity	7.57e-05	0.00332	CbGeAlD
Paroxetine—ABCB1—digestive system—obesity	7.31e-05	0.00321	CbGeAlD
Paroxetine—ABCB1—adrenal gland—obesity	6.96e-05	0.00306	CbGeAlD
Paroxetine—ABCB1—endocrine gland—obesity	6.04e-05	0.00265	CbGeAlD
Paroxetine—ABCB1—liver—obesity	5.44e-05	0.00239	CbGeAlD
Paroxetine—Nervousness—Bupropion—obesity	3.23e-05	0.000325	CcSEcCtD
Paroxetine—Oedema—Orlistat—obesity	3.22e-05	0.000324	CcSEcCtD
Paroxetine—Anaphylactic shock—Orlistat—obesity	3.22e-05	0.000324	CcSEcCtD
Paroxetine—Back pain—Bupropion—obesity	3.22e-05	0.000324	CcSEcCtD
Paroxetine—Orthostatic hypotension—Topiramate—obesity	3.21e-05	0.000323	CcSEcCtD
Paroxetine—Discomfort—Sibutramine—obesity	3.21e-05	0.000323	CcSEcCtD
Paroxetine—Hypokalaemia—Topiramate—obesity	3.2e-05	0.000322	CcSEcCtD
Paroxetine—Muscle spasms—Bupropion—obesity	3.2e-05	0.000322	CcSEcCtD
Paroxetine—Infection—Orlistat—obesity	3.2e-05	0.000321	CcSEcCtD
Paroxetine—Breast disorder—Topiramate—obesity	3.18e-05	0.00032	CcSEcCtD
Paroxetine—Dry mouth—Sibutramine—obesity	3.18e-05	0.000319	CcSEcCtD
Paroxetine—Aspartate aminotransferase increased—Topiramate—obesity	3.17e-05	0.000319	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Topiramate—obesity	3.17e-05	0.000319	CcSEcCtD
Paroxetine—Nervous system disorder—Orlistat—obesity	3.16e-05	0.000317	CcSEcCtD
Paroxetine—Nasopharyngitis—Topiramate—obesity	3.15e-05	0.000316	CcSEcCtD
Paroxetine—Confusional state—Sibutramine—obesity	3.14e-05	0.000316	CcSEcCtD
Paroxetine—Vision blurred—Bupropion—obesity	3.14e-05	0.000315	CcSEcCtD
Paroxetine—Skin disorder—Orlistat—obesity	3.13e-05	0.000314	CcSEcCtD
Paroxetine—Tremor—Bupropion—obesity	3.12e-05	0.000313	CcSEcCtD
Paroxetine—Gastritis—Topiramate—obesity	3.11e-05	0.000313	CcSEcCtD
Paroxetine—Anaphylactic shock—Sibutramine—obesity	3.11e-05	0.000313	CcSEcCtD
Paroxetine—Oedema—Sibutramine—obesity	3.11e-05	0.000313	CcSEcCtD
Paroxetine—Hyperhidrosis—Orlistat—obesity	3.11e-05	0.000313	CcSEcCtD
Paroxetine—Alanine aminotransferase increased—Topiramate—obesity	3.1e-05	0.000312	CcSEcCtD
Paroxetine—Muscular weakness—Topiramate—obesity	3.1e-05	0.000312	CcSEcCtD
Paroxetine—Infection—Sibutramine—obesity	3.09e-05	0.000311	CcSEcCtD
Paroxetine—Ill-defined disorder—Bupropion—obesity	3.09e-05	0.00031	CcSEcCtD
Paroxetine—Anaemia—Bupropion—obesity	3.07e-05	0.000309	CcSEcCtD
Paroxetine—Shock—Sibutramine—obesity	3.06e-05	0.000308	CcSEcCtD
Paroxetine—Agitation—Bupropion—obesity	3.06e-05	0.000307	CcSEcCtD
Paroxetine—Thrombocytopenia—Sibutramine—obesity	3.05e-05	0.000307	CcSEcCtD
Paroxetine—Asthma—Topiramate—obesity	3.04e-05	0.000306	CcSEcCtD
Paroxetine—Dysphagia—Topiramate—obesity	3.04e-05	0.000306	CcSEcCtD
Paroxetine—Angioedema—Bupropion—obesity	3.04e-05	0.000306	CcSEcCtD
Paroxetine—Tachycardia—Sibutramine—obesity	3.04e-05	0.000306	CcSEcCtD
Paroxetine—Skin disorder—Sibutramine—obesity	3.02e-05	0.000304	CcSEcCtD
Paroxetine—Eosinophilia—Topiramate—obesity	3.01e-05	0.000303	CcSEcCtD
Paroxetine—Hyperhidrosis—Sibutramine—obesity	3.01e-05	0.000303	CcSEcCtD
Paroxetine—Malaise—Bupropion—obesity	3e-05	0.000302	CcSEcCtD
Paroxetine—Vertigo—Bupropion—obesity	2.99e-05	0.000301	CcSEcCtD
Paroxetine—Syncope—Bupropion—obesity	2.98e-05	0.0003	CcSEcCtD
Paroxetine—Pancreatitis—Topiramate—obesity	2.98e-05	0.0003	CcSEcCtD
Paroxetine—Leukopenia—Bupropion—obesity	2.98e-05	0.000299	CcSEcCtD
Paroxetine—Angina pectoris—Topiramate—obesity	2.96e-05	0.000298	CcSEcCtD
Paroxetine—Sweating increased—Topiramate—obesity	2.96e-05	0.000298	CcSEcCtD
Paroxetine—Palpitations—Bupropion—obesity	2.94e-05	0.000296	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Orlistat—obesity	2.93e-05	0.000295	CcSEcCtD
Paroxetine—Bronchitis—Topiramate—obesity	2.93e-05	0.000294	CcSEcCtD
Paroxetine—Loss of consciousness—Bupropion—obesity	2.92e-05	0.000294	CcSEcCtD
Paroxetine—Insomnia—Orlistat—obesity	2.91e-05	0.000293	CcSEcCtD
Paroxetine—Hypotension—Sibutramine—obesity	2.91e-05	0.000293	CcSEcCtD
Paroxetine—Cough—Bupropion—obesity	2.9e-05	0.000292	CcSEcCtD
Paroxetine—Paraesthesia—Orlistat—obesity	2.89e-05	0.000291	CcSEcCtD
Paroxetine—Pancytopenia—Topiramate—obesity	2.89e-05	0.00029	CcSEcCtD
Paroxetine—Convulsion—Bupropion—obesity	2.88e-05	0.00029	CcSEcCtD
Paroxetine—Hypertension—Bupropion—obesity	2.87e-05	0.000289	CcSEcCtD
Paroxetine—Dysuria—Topiramate—obesity	2.84e-05	0.000286	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Sibutramine—obesity	2.84e-05	0.000285	CcSEcCtD
Paroxetine—Dyspepsia—Orlistat—obesity	2.83e-05	0.000285	CcSEcCtD
Paroxetine—Chest pain—Bupropion—obesity	2.83e-05	0.000285	CcSEcCtD
Paroxetine—Myalgia—Bupropion—obesity	2.83e-05	0.000285	CcSEcCtD
Paroxetine—Arthralgia—Bupropion—obesity	2.83e-05	0.000285	CcSEcCtD
Paroxetine—Anxiety—Bupropion—obesity	2.82e-05	0.000284	CcSEcCtD
Paroxetine—Insomnia—Sibutramine—obesity	2.82e-05	0.000283	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.81e-05	0.000283	CcSEcCtD
Paroxetine—Pollakiuria—Topiramate—obesity	2.81e-05	0.000283	CcSEcCtD
Paroxetine—Erectile dysfunction—Topiramate—obesity	2.8e-05	0.000282	CcSEcCtD
Paroxetine—Discomfort—Bupropion—obesity	2.8e-05	0.000281	CcSEcCtD
Paroxetine—Decreased appetite—Orlistat—obesity	2.8e-05	0.000281	CcSEcCtD
Paroxetine—Paraesthesia—Sibutramine—obesity	2.8e-05	0.000281	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Orlistat—obesity	2.78e-05	0.000279	CcSEcCtD
Paroxetine—Dyspnoea—Sibutramine—obesity	2.78e-05	0.000279	CcSEcCtD
Paroxetine—Photosensitivity reaction—Topiramate—obesity	2.78e-05	0.000279	CcSEcCtD
Paroxetine—Fatigue—Orlistat—obesity	2.77e-05	0.000279	CcSEcCtD
Paroxetine—Dry mouth—Bupropion—obesity	2.77e-05	0.000279	CcSEcCtD
Paroxetine—Somnolence—Sibutramine—obesity	2.77e-05	0.000278	CcSEcCtD
Paroxetine—Weight increased—Topiramate—obesity	2.77e-05	0.000278	CcSEcCtD
Paroxetine—Weight decreased—Topiramate—obesity	2.75e-05	0.000277	CcSEcCtD
Paroxetine—Pain—Orlistat—obesity	2.75e-05	0.000277	CcSEcCtD
Paroxetine—Hyperglycaemia—Topiramate—obesity	2.74e-05	0.000276	CcSEcCtD
Paroxetine—Dyspepsia—Sibutramine—obesity	2.74e-05	0.000276	CcSEcCtD
Paroxetine—Confusional state—Bupropion—obesity	2.74e-05	0.000275	CcSEcCtD
Paroxetine—Pneumonia—Topiramate—obesity	2.73e-05	0.000274	CcSEcCtD
Paroxetine—Anaphylactic shock—Bupropion—obesity	2.71e-05	0.000273	CcSEcCtD
Paroxetine—Oedema—Bupropion—obesity	2.71e-05	0.000273	CcSEcCtD
Paroxetine—Decreased appetite—Sibutramine—obesity	2.71e-05	0.000272	CcSEcCtD
Paroxetine—Depression—Topiramate—obesity	2.7e-05	0.000272	CcSEcCtD
Paroxetine—Infection—Bupropion—obesity	2.7e-05	0.000271	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Topiramate—obesity	2.69e-05	0.00027	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Sibutramine—obesity	2.69e-05	0.00027	CcSEcCtD
Paroxetine—Shock—Bupropion—obesity	2.67e-05	0.000269	CcSEcCtD
Paroxetine—Pain—Sibutramine—obesity	2.66e-05	0.000268	CcSEcCtD
Paroxetine—Constipation—Sibutramine—obesity	2.66e-05	0.000268	CcSEcCtD
Paroxetine—Nervous system disorder—Bupropion—obesity	2.66e-05	0.000268	CcSEcCtD
Paroxetine—Neuropathy peripheral—Topiramate—obesity	2.66e-05	0.000267	CcSEcCtD
Paroxetine—Thrombocytopenia—Bupropion—obesity	2.66e-05	0.000267	CcSEcCtD
Paroxetine—Feeling abnormal—Orlistat—obesity	2.65e-05	0.000267	CcSEcCtD
Paroxetine—Tachycardia—Bupropion—obesity	2.65e-05	0.000266	CcSEcCtD
Paroxetine—Stomatitis—Topiramate—obesity	2.64e-05	0.000266	CcSEcCtD
Paroxetine—Skin disorder—Bupropion—obesity	2.64e-05	0.000265	CcSEcCtD
Paroxetine—Urinary tract infection—Topiramate—obesity	2.64e-05	0.000265	CcSEcCtD
Paroxetine—Conjunctivitis—Topiramate—obesity	2.64e-05	0.000265	CcSEcCtD
Paroxetine—Gastrointestinal pain—Orlistat—obesity	2.63e-05	0.000265	CcSEcCtD
Paroxetine—Hyperhidrosis—Bupropion—obesity	2.62e-05	0.000264	CcSEcCtD
Paroxetine—Haematuria—Topiramate—obesity	2.59e-05	0.00026	CcSEcCtD
Paroxetine—Feeling abnormal—Sibutramine—obesity	2.57e-05	0.000258	CcSEcCtD
Paroxetine—Epistaxis—Topiramate—obesity	2.56e-05	0.000257	CcSEcCtD
Paroxetine—Urticaria—Orlistat—obesity	2.56e-05	0.000257	CcSEcCtD
Paroxetine—Gastrointestinal pain—Sibutramine—obesity	2.55e-05	0.000256	CcSEcCtD
Paroxetine—Sinusitis—Topiramate—obesity	2.54e-05	0.000256	CcSEcCtD
Paroxetine—Body temperature increased—Orlistat—obesity	2.54e-05	0.000256	CcSEcCtD
Paroxetine—Abdominal pain—Orlistat—obesity	2.54e-05	0.000256	CcSEcCtD
Paroxetine—Hypotension—Bupropion—obesity	2.54e-05	0.000255	CcSEcCtD
Paroxetine—Agranulocytosis—Topiramate—obesity	2.53e-05	0.000254	CcSEcCtD
Paroxetine—Bradycardia—Topiramate—obesity	2.48e-05	0.000249	CcSEcCtD
Paroxetine—Urticaria—Sibutramine—obesity	2.47e-05	0.000249	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Bupropion—obesity	2.47e-05	0.000249	CcSEcCtD
Paroxetine—Abdominal pain—Sibutramine—obesity	2.46e-05	0.000248	CcSEcCtD
Paroxetine—Body temperature increased—Sibutramine—obesity	2.46e-05	0.000248	CcSEcCtD
Paroxetine—Insomnia—Bupropion—obesity	2.46e-05	0.000247	CcSEcCtD
Paroxetine—Haemoglobin—Topiramate—obesity	2.45e-05	0.000246	CcSEcCtD
Paroxetine—Rhinitis—Topiramate—obesity	2.44e-05	0.000245	CcSEcCtD
Paroxetine—Paraesthesia—Bupropion—obesity	2.44e-05	0.000245	CcSEcCtD
Paroxetine—Haemorrhage—Topiramate—obesity	2.43e-05	0.000245	CcSEcCtD
Paroxetine—Hepatitis—Topiramate—obesity	2.43e-05	0.000245	CcSEcCtD
Paroxetine—Hallucination—Topiramate—obesity	2.42e-05	0.000244	CcSEcCtD
Paroxetine—Hypoaesthesia—Topiramate—obesity	2.42e-05	0.000244	CcSEcCtD
Paroxetine—Dyspnoea—Bupropion—obesity	2.42e-05	0.000243	CcSEcCtD
Paroxetine—Pharyngitis—Topiramate—obesity	2.42e-05	0.000243	CcSEcCtD
Paroxetine—Somnolence—Bupropion—obesity	2.41e-05	0.000243	CcSEcCtD
Paroxetine—Oedema peripheral—Topiramate—obesity	2.4e-05	0.000241	CcSEcCtD
Paroxetine—Connective tissue disorder—Topiramate—obesity	2.39e-05	0.000241	CcSEcCtD
Paroxetine—Dyspepsia—Bupropion—obesity	2.39e-05	0.00024	CcSEcCtD
Paroxetine—Hypersensitivity—Orlistat—obesity	2.37e-05	0.000238	CcSEcCtD
Paroxetine—Decreased appetite—Bupropion—obesity	2.36e-05	0.000237	CcSEcCtD
Paroxetine—Visual impairment—Topiramate—obesity	2.35e-05	0.000236	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Bupropion—obesity	2.34e-05	0.000236	CcSEcCtD
Paroxetine—Fatigue—Bupropion—obesity	2.34e-05	0.000235	CcSEcCtD
Paroxetine—Pain—Bupropion—obesity	2.32e-05	0.000233	CcSEcCtD
Paroxetine—Constipation—Bupropion—obesity	2.32e-05	0.000233	CcSEcCtD
Paroxetine—Asthenia—Orlistat—obesity	2.31e-05	0.000232	CcSEcCtD
Paroxetine—Erythema multiforme—Topiramate—obesity	2.3e-05	0.000231	CcSEcCtD
Paroxetine—Hypersensitivity—Sibutramine—obesity	2.29e-05	0.000231	CcSEcCtD
Paroxetine—Pruritus—Orlistat—obesity	2.28e-05	0.000229	CcSEcCtD
Paroxetine—Eye disorder—Topiramate—obesity	2.28e-05	0.000229	CcSEcCtD
Paroxetine—Tinnitus—Topiramate—obesity	2.27e-05	0.000228	CcSEcCtD
Paroxetine—Cardiac disorder—Topiramate—obesity	2.26e-05	0.000227	CcSEcCtD
Paroxetine—Flushing—Topiramate—obesity	2.26e-05	0.000227	CcSEcCtD
Paroxetine—Feeling abnormal—Bupropion—obesity	2.24e-05	0.000225	CcSEcCtD
Paroxetine—Asthenia—Sibutramine—obesity	2.23e-05	0.000225	CcSEcCtD
Paroxetine—Gastrointestinal pain—Bupropion—obesity	2.22e-05	0.000223	CcSEcCtD
Paroxetine—Angiopathy—Topiramate—obesity	2.21e-05	0.000222	CcSEcCtD
Paroxetine—Pruritus—Sibutramine—obesity	2.2e-05	0.000222	CcSEcCtD
Paroxetine—Diarrhoea—Orlistat—obesity	2.2e-05	0.000221	CcSEcCtD
Paroxetine—Immune system disorder—Topiramate—obesity	2.2e-05	0.000221	CcSEcCtD
Paroxetine—Mediastinal disorder—Topiramate—obesity	2.19e-05	0.000221	CcSEcCtD
Paroxetine—Chills—Topiramate—obesity	2.18e-05	0.00022	CcSEcCtD
Paroxetine—Urticaria—Bupropion—obesity	2.16e-05	0.000217	CcSEcCtD
Paroxetine—Alopecia—Topiramate—obesity	2.15e-05	0.000216	CcSEcCtD
Paroxetine—Body temperature increased—Bupropion—obesity	2.15e-05	0.000216	CcSEcCtD
Paroxetine—Abdominal pain—Bupropion—obesity	2.15e-05	0.000216	CcSEcCtD
Paroxetine—Mental disorder—Topiramate—obesity	2.13e-05	0.000214	CcSEcCtD
Paroxetine—Diarrhoea—Sibutramine—obesity	2.13e-05	0.000214	CcSEcCtD
Paroxetine—Dizziness—Orlistat—obesity	2.13e-05	0.000214	CcSEcCtD
Paroxetine—Erythema—Topiramate—obesity	2.12e-05	0.000213	CcSEcCtD
Paroxetine—Malnutrition—Topiramate—obesity	2.12e-05	0.000213	CcSEcCtD
Paroxetine—Flatulence—Topiramate—obesity	2.09e-05	0.00021	CcSEcCtD
Paroxetine—Tension—Topiramate—obesity	2.08e-05	0.000209	CcSEcCtD
Paroxetine—Dysgeusia—Topiramate—obesity	2.08e-05	0.000209	CcSEcCtD
Paroxetine—Dizziness—Sibutramine—obesity	2.06e-05	0.000207	CcSEcCtD
Paroxetine—Nervousness—Topiramate—obesity	2.06e-05	0.000207	CcSEcCtD
Paroxetine—Back pain—Topiramate—obesity	2.05e-05	0.000206	CcSEcCtD
Paroxetine—Vomiting—Orlistat—obesity	2.05e-05	0.000206	CcSEcCtD
Paroxetine—Muscle spasms—Topiramate—obesity	2.04e-05	0.000205	CcSEcCtD
Paroxetine—Rash—Orlistat—obesity	2.03e-05	0.000204	CcSEcCtD
Paroxetine—Dermatitis—Orlistat—obesity	2.03e-05	0.000204	CcSEcCtD
Paroxetine—Headache—Orlistat—obesity	2.02e-05	0.000203	CcSEcCtD
Paroxetine—Hypersensitivity—Bupropion—obesity	2e-05	0.000201	CcSEcCtD
Paroxetine—Vision blurred—Topiramate—obesity	2e-05	0.000201	CcSEcCtD
Paroxetine—Tremor—Topiramate—obesity	1.99e-05	0.0002	CcSEcCtD
Paroxetine—Vomiting—Sibutramine—obesity	1.98e-05	0.000199	CcSEcCtD
Paroxetine—Ill-defined disorder—Topiramate—obesity	1.97e-05	0.000198	CcSEcCtD
Paroxetine—Rash—Sibutramine—obesity	1.96e-05	0.000197	CcSEcCtD
Paroxetine—Dermatitis—Sibutramine—obesity	1.96e-05	0.000197	CcSEcCtD
Paroxetine—Anaemia—Topiramate—obesity	1.96e-05	0.000197	CcSEcCtD
Paroxetine—Headache—Sibutramine—obesity	1.95e-05	0.000196	CcSEcCtD
Paroxetine—Asthenia—Bupropion—obesity	1.95e-05	0.000196	CcSEcCtD
Paroxetine—Agitation—Topiramate—obesity	1.95e-05	0.000196	CcSEcCtD
Paroxetine—Pruritus—Bupropion—obesity	1.92e-05	0.000193	CcSEcCtD
Paroxetine—Nausea—Orlistat—obesity	1.91e-05	0.000192	CcSEcCtD
Paroxetine—Malaise—Topiramate—obesity	1.91e-05	0.000192	CcSEcCtD
Paroxetine—Vertigo—Topiramate—obesity	1.9e-05	0.000191	CcSEcCtD
Paroxetine—Syncope—Topiramate—obesity	1.9e-05	0.000191	CcSEcCtD
Paroxetine—Leukopenia—Topiramate—obesity	1.9e-05	0.000191	CcSEcCtD
Paroxetine—Palpitations—Topiramate—obesity	1.87e-05	0.000188	CcSEcCtD
Paroxetine—Loss of consciousness—Topiramate—obesity	1.86e-05	0.000187	CcSEcCtD
Paroxetine—Diarrhoea—Bupropion—obesity	1.86e-05	0.000187	CcSEcCtD
Paroxetine—Nausea—Sibutramine—obesity	1.85e-05	0.000186	CcSEcCtD
Paroxetine—Cough—Topiramate—obesity	1.85e-05	0.000186	CcSEcCtD
Paroxetine—Convulsion—Topiramate—obesity	1.84e-05	0.000185	CcSEcCtD
Paroxetine—Hypertension—Topiramate—obesity	1.83e-05	0.000184	CcSEcCtD
Paroxetine—Myalgia—Topiramate—obesity	1.8e-05	0.000181	CcSEcCtD
Paroxetine—Chest pain—Topiramate—obesity	1.8e-05	0.000181	CcSEcCtD
Paroxetine—Arthralgia—Topiramate—obesity	1.8e-05	0.000181	CcSEcCtD
Paroxetine—Anxiety—Topiramate—obesity	1.8e-05	0.000181	CcSEcCtD
Paroxetine—Dizziness—Bupropion—obesity	1.8e-05	0.000181	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.79e-05	0.00018	CcSEcCtD
Paroxetine—Discomfort—Topiramate—obesity	1.78e-05	0.000179	CcSEcCtD
Paroxetine—Dry mouth—Topiramate—obesity	1.76e-05	0.000177	CcSEcCtD
Paroxetine—Confusional state—Topiramate—obesity	1.74e-05	0.000175	CcSEcCtD
Paroxetine—Oedema—Topiramate—obesity	1.73e-05	0.000174	CcSEcCtD
Paroxetine—Vomiting—Bupropion—obesity	1.73e-05	0.000174	CcSEcCtD
Paroxetine—Infection—Topiramate—obesity	1.72e-05	0.000173	CcSEcCtD
Paroxetine—Rash—Bupropion—obesity	1.71e-05	0.000172	CcSEcCtD
Paroxetine—Dermatitis—Bupropion—obesity	1.71e-05	0.000172	CcSEcCtD
Paroxetine—Shock—Topiramate—obesity	1.7e-05	0.000171	CcSEcCtD
Paroxetine—Headache—Bupropion—obesity	1.7e-05	0.000171	CcSEcCtD
Paroxetine—Nervous system disorder—Topiramate—obesity	1.7e-05	0.000171	CcSEcCtD
Paroxetine—Thrombocytopenia—Topiramate—obesity	1.69e-05	0.00017	CcSEcCtD
Paroxetine—Tachycardia—Topiramate—obesity	1.69e-05	0.00017	CcSEcCtD
Paroxetine—Skin disorder—Topiramate—obesity	1.68e-05	0.000169	CcSEcCtD
Paroxetine—Hyperhidrosis—Topiramate—obesity	1.67e-05	0.000168	CcSEcCtD
Paroxetine—Hypotension—Topiramate—obesity	1.62e-05	0.000163	CcSEcCtD
Paroxetine—Nausea—Bupropion—obesity	1.61e-05	0.000162	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Topiramate—obesity	1.58e-05	0.000158	CcSEcCtD
Paroxetine—Insomnia—Topiramate—obesity	1.56e-05	0.000157	CcSEcCtD
Paroxetine—Paraesthesia—Topiramate—obesity	1.55e-05	0.000156	CcSEcCtD
Paroxetine—Dyspnoea—Topiramate—obesity	1.54e-05	0.000155	CcSEcCtD
Paroxetine—Somnolence—Topiramate—obesity	1.54e-05	0.000155	CcSEcCtD
Paroxetine—Dyspepsia—Topiramate—obesity	1.52e-05	0.000153	CcSEcCtD
Paroxetine—Decreased appetite—Topiramate—obesity	1.5e-05	0.000151	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Topiramate—obesity	1.49e-05	0.00015	CcSEcCtD
Paroxetine—Fatigue—Topiramate—obesity	1.49e-05	0.00015	CcSEcCtD
Paroxetine—Pain—Topiramate—obesity	1.48e-05	0.000149	CcSEcCtD
Paroxetine—Constipation—Topiramate—obesity	1.48e-05	0.000149	CcSEcCtD
Paroxetine—Feeling abnormal—Topiramate—obesity	1.43e-05	0.000143	CcSEcCtD
Paroxetine—Gastrointestinal pain—Topiramate—obesity	1.41e-05	0.000142	CcSEcCtD
Paroxetine—Urticaria—Topiramate—obesity	1.37e-05	0.000138	CcSEcCtD
Paroxetine—Abdominal pain—Topiramate—obesity	1.37e-05	0.000137	CcSEcCtD
Paroxetine—Body temperature increased—Topiramate—obesity	1.37e-05	0.000137	CcSEcCtD
Paroxetine—Hypersensitivity—Topiramate—obesity	1.27e-05	0.000128	CcSEcCtD
Paroxetine—Asthenia—Topiramate—obesity	1.24e-05	0.000125	CcSEcCtD
Paroxetine—Pruritus—Topiramate—obesity	1.22e-05	0.000123	CcSEcCtD
Paroxetine—Diarrhoea—Topiramate—obesity	1.18e-05	0.000119	CcSEcCtD
Paroxetine—Dizziness—Topiramate—obesity	1.14e-05	0.000115	CcSEcCtD
Paroxetine—Vomiting—Topiramate—obesity	1.1e-05	0.000111	CcSEcCtD
Paroxetine—Rash—Topiramate—obesity	1.09e-05	0.00011	CcSEcCtD
Paroxetine—Dermatitis—Topiramate—obesity	1.09e-05	0.00011	CcSEcCtD
Paroxetine—Headache—Topiramate—obesity	1.08e-05	0.000109	CcSEcCtD
Paroxetine—Nausea—Topiramate—obesity	1.03e-05	0.000103	CcSEcCtD
Paroxetine—HTR2A—Signaling Pathways—BAD—obesity	1.09e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GNB3—obesity	1.08e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARGC1A—obesity	1.08e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—obesity	1.08e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MTHFR—obesity	1.08e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—BAD—obesity	1.08e-06	1.81e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—F2—obesity	1.08e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PRKCB—obesity	1.08e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—HMOX1—obesity	1.08e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—BAD—obesity	1.08e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GNB3—obesity	1.07e-06	1.79e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARGC1A—obesity	1.07e-06	1.79e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3CG—obesity	1.07e-06	1.79e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—HMOX1—obesity	1.07e-06	1.79e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—BAD—obesity	1.07e-06	1.78e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARA—obesity	1.06e-06	1.77e-05	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—AKT1—obesity	1.06e-06	1.77e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GNAS—obesity	1.05e-06	1.76e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3CG—obesity	1.05e-06	1.76e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3CG—obesity	1.05e-06	1.75e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—LPL—obesity	1.05e-06	1.75e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GNAS—obesity	1.04e-06	1.75e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3CG—obesity	1.04e-06	1.74e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—obesity	1.04e-06	1.74e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IRS1—obesity	1.04e-06	1.74e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPARG—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PIK3R1—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IRS1—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3CG—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOB—obesity	1.03e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IRS1—obesity	1.03e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AGT—obesity	1.03e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOB—obesity	1.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—obesity	1.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IRS1—obesity	1.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GPX1—obesity	1.02e-06	1.71e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—INS—obesity	1.01e-06	1.7e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOE—obesity	1.01e-06	1.68e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MAPK8—obesity	1e-06	1.68e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—AKT1—obesity	1e-06	1.67e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—obesity	1e-06	1.67e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CAV1—obesity	9.96e-07	1.67e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—obesity	9.95e-07	1.66e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—INS—obesity	9.95e-07	1.66e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOA1—obesity	9.94e-07	1.66e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CD36—obesity	9.93e-07	1.66e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—obesity	9.92e-07	1.66e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—INS—obesity	9.9e-07	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—obesity	9.89e-07	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—INS—obesity	9.86e-07	1.65e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—LPL—obesity	9.85e-07	1.65e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—obesity	9.82e-07	1.64e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL2—obesity	9.79e-07	1.64e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—INS—obesity	9.77e-07	1.63e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—LPL—obesity	9.76e-07	1.63e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL2—obesity	9.74e-07	1.63e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL2—obesity	9.71e-07	1.62e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IGF1—obesity	9.62e-07	1.61e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MAPK8—obesity	9.62e-07	1.61e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AKT2—obesity	9.62e-07	1.61e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL2—obesity	9.61e-07	1.61e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GPX1—obesity	9.61e-07	1.61e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—AKT1—obesity	9.59e-07	1.6e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IGF1—obesity	9.57e-07	1.6e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AKT2—obesity	9.56e-07	1.6e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PIK3CB—obesity	9.55e-07	1.6e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IGF1—obesity	9.54e-07	1.6e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AKT2—obesity	9.53e-07	1.59e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GPX1—obesity	9.53e-07	1.59e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.52e-07	1.59e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—obesity	9.46e-07	1.58e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IGF1—obesity	9.45e-07	1.58e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AKT2—obesity	9.44e-07	1.58e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3CD—obesity	9.42e-07	1.58e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTHFR—obesity	9.41e-07	1.57e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CD36—obesity	9.36e-07	1.57e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—obesity	9.3e-07	1.56e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CD36—obesity	9.28e-07	1.55e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3CD—obesity	9.24e-07	1.55e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARA—obesity	9.23e-07	1.54e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3CD—obesity	9.19e-07	1.54e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—STAT3—obesity	9.18e-07	1.54e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3CD—obesity	9.16e-07	1.53e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—PIK3CA—obesity	9.15e-07	1.53e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SERPINE1—obesity	9.14e-07	1.53e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	9.1e-07	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SERPINE1—obesity	9.09e-07	1.52e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3CG—obesity	9.08e-07	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	9.07e-07	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3CD—obesity	9.07e-07	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SERPINE1—obesity	9.06e-07	1.52e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	8.99e-07	1.5e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SERPINE1—obesity	8.97e-07	1.5e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AGT—obesity	8.94e-07	1.5e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3R1—obesity	8.9e-07	1.49e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—obesity	8.9e-07	1.49e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TYK2—obesity	8.89e-07	1.49e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTHFR—obesity	8.87e-07	1.48e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TYK2—obesity	8.84e-07	1.48e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RHOA—obesity	8.82e-07	1.47e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TYK2—obesity	8.81e-07	1.47e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTHFR—obesity	8.79e-07	1.47e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT3—obesity	8.79e-07	1.47e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RHOA—obesity	8.77e-07	1.47e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOE—obesity	8.76e-07	1.47e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPARG—obesity	8.76e-07	1.47e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RHOA—obesity	8.74e-07	1.46e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TYK2—obesity	8.73e-07	1.46e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—obesity	8.72e-07	1.46e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3R1—obesity	8.72e-07	1.46e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARA—obesity	8.7e-07	1.46e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAV1—obesity	8.68e-07	1.45e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—obesity	8.68e-07	1.45e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3R1—obesity	8.68e-07	1.45e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOA1—obesity	8.66e-07	1.45e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RHOA—obesity	8.66e-07	1.45e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—obesity	8.65e-07	1.45e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3R1—obesity	8.65e-07	1.45e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—obesity	8.64e-07	1.44e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARA—obesity	8.63e-07	1.44e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—INS—obesity	8.59e-07	1.44e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—obesity	8.57e-07	1.43e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3R1—obesity	8.57e-07	1.43e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MYC—obesity	8.53e-07	1.43e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—obesity	8.51e-07	1.42e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AGT—obesity	8.43e-07	1.41e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AGT—obesity	8.35e-07	1.4e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—PIK3CA—obesity	8.31e-07	1.39e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—PIK3CA—obesity	8.27e-07	1.38e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOE—obesity	8.26e-07	1.38e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—PIK3CA—obesity	8.24e-07	1.38e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3CB—obesity	8.21e-07	1.37e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOE—obesity	8.19e-07	1.37e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAV1—obesity	8.18e-07	1.37e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MYC—obesity	8.17e-07	1.37e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOA1—obesity	8.16e-07	1.36e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—PIK3CA—obesity	8.16e-07	1.36e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—obesity	8.15e-07	1.36e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—obesity	8.14e-07	1.36e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAV1—obesity	8.11e-07	1.36e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOA1—obesity	8.09e-07	1.35e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MTOR—obesity	8.05e-07	1.35e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3CB—obesity	8.05e-07	1.35e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3CB—obesity	8.01e-07	1.34e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MTOR—obesity	8.01e-07	1.34e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3CB—obesity	7.98e-07	1.34e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MTOR—obesity	7.98e-07	1.34e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3CD—obesity	7.98e-07	1.33e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3CG—obesity	7.91e-07	1.32e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MTOR—obesity	7.91e-07	1.32e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3CB—obesity	7.91e-07	1.32e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—obesity	7.88e-07	1.32e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.75e-07	1.3e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPARG—obesity	7.63e-07	1.28e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3R1—obesity	7.53e-07	1.26e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—obesity	7.53e-07	1.26e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—obesity	7.53e-07	1.26e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—INS—obesity	7.49e-07	1.25e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—AKT1—obesity	7.48e-07	1.25e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3CG—obesity	7.45e-07	1.25e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—AKT1—obesity	7.44e-07	1.24e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—AKT1—obesity	7.41e-07	1.24e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3CG—obesity	7.39e-07	1.24e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—obesity	7.36e-07	1.23e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—AKT1—obesity	7.34e-07	1.23e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—obesity	7.32e-07	1.22e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—obesity	7.3e-07	1.22e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PIK3CA—obesity	7.24e-07	1.21e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—obesity	7.23e-07	1.21e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPARG—obesity	7.19e-07	1.2e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPARG—obesity	7.13e-07	1.19e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—obesity	7.09e-07	1.19e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—INS—obesity	7.05e-07	1.18e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—obesity	7.03e-07	1.18e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—obesity	7e-07	1.17e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—INS—obesity	6.99e-07	1.17e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—obesity	6.96e-07	1.16e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3CB—obesity	6.95e-07	1.16e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3CD—obesity	6.95e-07	1.16e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—obesity	6.94e-07	1.16e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PIK3CA—obesity	6.94e-07	1.16e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—obesity	6.89e-07	1.15e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—obesity	6.87e-07	1.15e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—obesity	6.86e-07	1.15e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MAPK8—obesity	6.81e-07	1.14e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—AKT1—obesity	6.79e-07	1.14e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MAPK8—obesity	6.77e-07	1.13e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—AKT1—obesity	6.75e-07	1.13e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MAPK8—obesity	6.75e-07	1.13e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—AKT1—obesity	6.73e-07	1.13e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MAPK8—obesity	6.68e-07	1.12e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—AKT1—obesity	6.67e-07	1.11e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—obesity	6.56e-07	1.1e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3R1—obesity	6.56e-07	1.1e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3CD—obesity	6.55e-07	1.1e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3CD—obesity	6.49e-07	1.09e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—obesity	6.47e-07	1.08e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—obesity	6.41e-07	1.07e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—obesity	6.41e-07	1.07e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT3—obesity	6.22e-07	1.04e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT3—obesity	6.19e-07	1.04e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—obesity	6.19e-07	1.03e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3R1—obesity	6.19e-07	1.03e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT3—obesity	6.17e-07	1.03e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—obesity	6.14e-07	1.03e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3R1—obesity	6.13e-07	1.03e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—obesity	6.13e-07	1.03e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT3—obesity	6.11e-07	1.02e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3CB—obesity	6.06e-07	1.01e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—obesity	6e-07	1e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—AKT1—obesity	5.92e-07	9.89e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PIK3CA—obesity	5.82e-07	9.74e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MYC—obesity	5.78e-07	9.67e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—obesity	5.77e-07	9.65e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MYC—obesity	5.75e-07	9.62e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—obesity	5.74e-07	9.6e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MYC—obesity	5.73e-07	9.59e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—obesity	5.72e-07	9.57e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3CB—obesity	5.71e-07	9.55e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MYC—obesity	5.68e-07	9.5e-06	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—AKT1—obesity	5.67e-07	9.47e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—obesity	5.66e-07	9.47e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3CB—obesity	5.66e-07	9.47e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—obesity	5.66e-07	9.46e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—obesity	5.61e-07	9.38e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PIK3CA—obesity	5.01e-07	8.38e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PIK3CA—obesity	4.91e-07	8.21e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PIK3CA—obesity	4.88e-07	8.17e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PIK3CA—obesity	4.87e-07	8.14e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PIK3CA—obesity	4.82e-07	8.06e-06	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—AKT1—obesity	4.76e-07	7.95e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—obesity	4.35e-07	7.27e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—obesity	4.32e-07	7.23e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—obesity	4.31e-07	7.21e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—obesity	4.27e-07	7.14e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PIK3CA—obesity	4.24e-07	7.09e-06	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—AKT1—obesity	4.09e-07	6.84e-06	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—AKT1—obesity	4.01e-07	6.71e-06	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—AKT1—obesity	3.99e-07	6.67e-06	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—AKT1—obesity	3.98e-07	6.65e-06	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—AKT1—obesity	3.94e-07	6.59e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PIK3CA—obesity	3.69e-07	6.18e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PIK3CA—obesity	3.48e-07	5.82e-06	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—AKT1—obesity	3.46e-07	5.79e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PIK3CA—obesity	3.45e-07	5.77e-06	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—AKT1—obesity	3.02e-07	5.05e-06	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—AKT1—obesity	2.84e-07	4.76e-06	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—AKT1—obesity	2.82e-07	4.71e-06	CbGpPWpGaD
